Advances in the clinical management of uveal melanoma

RD Carvajal, JJ Sacco, MJ Jager… - Nature Reviews …, 2023 - nature.com
Melanomas arising in the uveal tract of the eye are a rare form of the disease with a biology
and clinical phenotype distinct from their more common cutaneous counterparts. Treatment …

MAPK/ERK signaling pathway in hepatocellular carcinoma

H Moon, SW Ro - Cancers, 2021 - mdpi.com
Simple Summary The mitogen-activated protein kinase/extracellular signal-regulated kinase
(MAPK/ERK) signaling pathway is frequently activated in liver cancer, which is one of the …

MEK inhibitor resistance mechanisms and recent developments in combination trials

E Kun, YTM Tsang, CW Ng, DM Gershenson… - Cancer treatment …, 2021 - Elsevier
The mitogen-activated protein kinase (MAPK) pathway plays a vital role in cellular
processes such as gene expression, cell proliferation, cell survival, and apoptosis. Also …

A novel stimuli‐responsive injectable antibacterial hydrogel to achieve synergetic photothermal/gene‐targeted therapy towards uveal melanoma

S Wang, B Chen, L Ouyang, D Wang, J Tan… - Advanced …, 2021 - Wiley Online Library
Uveal melanoma (UM) is the most prevalent primary intraocular malignant tumor with a high
lethal rate. Patients who undergo conventional enucleation treatments consistently suffer …

The WNT/ROR pathway in cancer: from signaling to therapeutic intervention

K Menck, S Heinrichs, C Baden, A Bleckmann - Cells, 2021 - mdpi.com
The WNT pathway is one of the major signaling cascades frequently deregulated in human
cancer. While research had initially focused on signal transduction centered on β-catenin as …

HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non–small cell lung cancer

LJ Eichner, SD Curtis, SN Brun, CK McGuire… - Science …, 2023 - science.org
HDAC3 is one of the main targets of histone deacetylase (HDAC) inhibitors in clinical
development as cancer therapies, yet the in vivo role of HDAC3 in solid tumors is unknown …

Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma

JS Paradis, M Acosta, R Saddawi-Konefka… - Clinical Cancer …, 2021 - AACR
Purpose: Uveal melanoma is the most common eye cancer in adults. Approximately 50% of
patients with uveal melanoma develop metastatic uveal melanoma (mUM) in the liver, even …

Update on uveal melanoma: Translational research from biology to clinical practice

MA Ortega, O Fraile-Martinez… - International …, 2020 - spandidos-publications.com
Uveal melanoma is the most common type of intraocular cancer with a low mean annual
incidence of 5-10 cases per million. Tumours are located in the choroid (90%), ciliary body …

GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer

Y Long, J Guo, J Chen, J Sun, H Wang… - … and Targeted Therapy, 2023 - nature.com
In the treatment of most malignancies, radiotherapy plays a significant role. However, the
resistance of cancer cells to ionizing radiation (IR) is the main reason for the failure of …

Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma

P Chai, R Jia, Y Li, C Zhou, X Gu, L Yang, H Shi… - Progress in retinal and …, 2022 - Elsevier
Uveal melanoma (UM) and retinoblastoma (RB), which cause blindness and even death,
are the most frequently observed primary intraocular malignancies in adults and children …